 |
alirocumab |
|---|---|
| Trade Name | |
| Orphan Indication | Homozygous Familial Hypercholesterolemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Sanofi-Aventis US, LLC;55 Corporate Drive;Bridgewater, New Jersey, 08807 |
| |
alirocumab |
|---|---|
| Trade Name | |
| Orphan Indication | Homozygous Familial Hypercholesterolemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Sanofi-Aventis US, LLC;55 Corporate Drive;Bridgewater, New Jersey, 08807 |